Effect of pregnancy on long-term kidney function in renal transplant recipients treated with cyclosporine and with azathioprine
Standard
Effect of pregnancy on long-term kidney function in renal transplant recipients treated with cyclosporine and with azathioprine. / Fischer, Thorsten; Neumayer, Hans-Hellmut; Fischer, Ronald; Barenbrock, Michael; Schobel, Hans P; Lattrell, Barbara C; Jacobs, Volker R; Paepke, Stefan; von Steinburg, Stephanie Pildner; Schmalfeldt, Barbara; Schneider, Karl Theo M; Budde, Klemens.
In: AM J TRANSPLANT, Vol. 5, No. 11, 11.2005, p. 2732-9.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Effect of pregnancy on long-term kidney function in renal transplant recipients treated with cyclosporine and with azathioprine
AU - Fischer, Thorsten
AU - Neumayer, Hans-Hellmut
AU - Fischer, Ronald
AU - Barenbrock, Michael
AU - Schobel, Hans P
AU - Lattrell, Barbara C
AU - Jacobs, Volker R
AU - Paepke, Stefan
AU - von Steinburg, Stephanie Pildner
AU - Schmalfeldt, Barbara
AU - Schneider, Karl Theo M
AU - Budde, Klemens
PY - 2005/11
Y1 - 2005/11
N2 - In order to investigate the effect of different immunosuppressive regimens and the time interval between transplantation and pregnancy on long-term outcome, we performed a case-control study in pregnant renal allograft recipients. Eighty-one pregnancies of kidney transplanted recipients were identified [cyclosporine (CYA): n = 40; azathioprine (AZA): n = 41]. Controls were matched with respect to important prognostic factors. Posttransplant follow-up was 91.3 +/- 5 months. Graft and patient survival were similar in both groups and there was no apparent effect of immunosuppression. A total of 28 recipients (33%) delivered within 2 years and 6 (8%) subjects within 1 year after transplantation, but these short transplantation-to-pregnancy intervals had no apparent adverse effect on long-term outcome. In contrast to AZA-treated patients, CYA-treated patients experienced an increase in serum creatinine postpartum (1.15 +/- 0.2 mg/dL vs. 1.61 +/- 0.1 mg/dL; p < 0.05). Whole blood CYA levels decreased transiently during pregnancy from 115.9 +/- 8 ng/mL to 80.7 +/- 7 ng/mL leading to a gradual increase in drug dose from 240 +/- 14 mg/day to 324 +/- 21 mg/day (p < 0.05). Following delivery, there was an increase in CYA concentrations to 173 +/- 5.4 ng/mL, requiring rapid dose tapering to baseline of 246 +/- 15 mg/day. Pregnancies in renal recipients do not affect long-term patient and graft survival, independent of the immunosuppression. No detrimental effect of short transplantation-to-pregnancy intervals on long-term graft function was detected.
AB - In order to investigate the effect of different immunosuppressive regimens and the time interval between transplantation and pregnancy on long-term outcome, we performed a case-control study in pregnant renal allograft recipients. Eighty-one pregnancies of kidney transplanted recipients were identified [cyclosporine (CYA): n = 40; azathioprine (AZA): n = 41]. Controls were matched with respect to important prognostic factors. Posttransplant follow-up was 91.3 +/- 5 months. Graft and patient survival were similar in both groups and there was no apparent effect of immunosuppression. A total of 28 recipients (33%) delivered within 2 years and 6 (8%) subjects within 1 year after transplantation, but these short transplantation-to-pregnancy intervals had no apparent adverse effect on long-term outcome. In contrast to AZA-treated patients, CYA-treated patients experienced an increase in serum creatinine postpartum (1.15 +/- 0.2 mg/dL vs. 1.61 +/- 0.1 mg/dL; p < 0.05). Whole blood CYA levels decreased transiently during pregnancy from 115.9 +/- 8 ng/mL to 80.7 +/- 7 ng/mL leading to a gradual increase in drug dose from 240 +/- 14 mg/day to 324 +/- 21 mg/day (p < 0.05). Following delivery, there was an increase in CYA concentrations to 173 +/- 5.4 ng/mL, requiring rapid dose tapering to baseline of 246 +/- 15 mg/day. Pregnancies in renal recipients do not affect long-term patient and graft survival, independent of the immunosuppression. No detrimental effect of short transplantation-to-pregnancy intervals on long-term graft function was detected.
KW - Adult
KW - Azathioprine
KW - Creatinine
KW - Cyclosporine
KW - Female
KW - Follow-Up Studies
KW - Graft Survival
KW - Humans
KW - Immunosuppressive Agents
KW - Kidney Function Tests
KW - Kidney Transplantation
KW - Pregnancy
KW - Pregnancy Outcome
KW - Survival Analysis
U2 - 10.1111/j.1600-6143.2005.01091.x
DO - 10.1111/j.1600-6143.2005.01091.x
M3 - SCORING: Journal article
C2 - 16212634
VL - 5
SP - 2732
EP - 2739
JO - AM J TRANSPLANT
JF - AM J TRANSPLANT
SN - 1600-6135
IS - 11
ER -